Articles tagged with "chronic rhinosinusitis"

Saline Irrigation Effective in Treating CRS

Is the use of topical nasal therapies with saline alone and in combination with antibiotics, antifungals or corticosteroids effective in the treatment of chronic rhinosinusitis (CRS)?

Literature Review: A Roundup of Important Recent Studies

Wide variation in maximal medical therapy for CRS; "sinus headache" diagnosis and treatment; hospital-acquired conditions after HN cancer surgery uncommon but costly; tympanoplasty plus mastoidectomy in perforations; transoral BOT resection effective for OSA; type 1 GPT improves vocal outcomes in GI

Literature Review: A Roundup of Important Recent Studies

Oral steroids in chronic rhinosinusitis; macrolide therapy for chronic rhinosinusitis; parotid gland lymphoma consideration in parotid lesion evaluation; better dialogues with patients may minimize liability in cranial nerve injury malpractice trials; obesity in children with OSA can lead to depression, withdrawal; many otolaryngologists dissatisfied with current sinus CT results
 

Literature Review: A Roundup of Important Recent Studies

MRI cost justified in dysosmia; ESS superior to medical therapy for QOL in CRS; First-line steroid therapy can improve outcomes for ISSHL; TORS total laryngectomy effective for salvage surgery; Cidofovir effective for recurrent respiratory papillomatosis; High-volume academic medical centers have lower complication rates for head and neck oncologic surgery

Drug-Eluting Sinus Stent Hits the Market: May help maintain patency after FESS

Maintaining sinus patency after functional endoscopic sinus surgery (FESS) for chronic rhinosinusitis (CRS) has long been an issue; as many as 23 to 47 percent of patients require revision surgery after FESS. Now, a new drug-eluting, bioabsorbable stent manufactured by Intersect (Palo Alto, Calif.) is being billed as a “breakthrough treatment [that] improves outcomes for sinus surgery,” according to a news release from the company. The device, which received pre-market approval from the U.S. Food and Drug Administration (FDA) in August, has been studied since 2008. It is currently available in Texas, New York, Philadelphia, New Jersey, Atlanta, Ohio and Kentucky.

Concurrent Septoplasty Does Not Affect CRS-Specific Health-Related QOL

Are chronic rhinosinusitis (CRS)-specific health-related quality of life (HRQOL) outcomes affected by concurrent septoplasty performed during endoscopic sinus surgery (ESS) for medically refractory CRS? Background: Septoplasty is commonly performed during ESS. […]